Brief: Spectral provides regulatory update on its PMA submission for Toraymyxin

Spectral Medical

21/09/2017 13:00

Sept 21 (Reuters) - Spectral Medical Inc  EDT.TO  
    * Spectral provides regulatory update on its PMA submission 
for Toraymyxin(TM) 
    * Spectral Medical Inc - has been engaged in an ongoing 
interactive review process with FDA 
    * Spectral Medical Inc - expects to receive more detailed 
feedback from FDA on PMA submission in Q4 of 2017 
    * Spectral Medical -continues to be involved in a review 
process with FDA and Health Canada for its SAM continuous renal 
replacement therapy instrument 
 
Source text for Eikon:  ID:nCCN4hQk0a  
Further company coverage:  EDT.TO  
 
 ((bangalore.newsroom@thomsonreuters.com;))